- Highly respected South African Businessman, Mr Sipho Maseko, former CEO of Telkom SA Soc Ltd and MD of Vodacom SA, Has Joined the Board of Directors of ASP Isotopes Inc. - Dr. Hendrik Strydom, PhD, Chief Technology Officer of ASP Isotopes Inc., is transitioning from the Board of Directors of ASP Isotopes Inc. to the Board of Managers of Quantum Leap Energy LLC. - The Company Intends to pursue the Separation of its Nuclear Fuels Business, Quantum Leap Energy LLC, and Specialist Isotope Products and Related Services Business in Two Independent Companies during 2H 2025. WASHINGTON, April 15, 2025 (GLOBE NEWSWIRE) -- ASP Isotopes Inc. NASDAQ: ASPI ("ASP Isotopes" or the "Company"),

- Ytterbium-176 is a critical material used in the production of radioisotopes for oncology treatments, including Novartis' Pluvicto. - The Company expects to be able to achieve a 99.75% enrichment for Ytterbium-176 and offer highly enriched Ytterbium-176 for commercial sale during 2025. - The Company anticipates now being able to proceed with the plans to construct Nickel-64, Gadolinium-160 and Lithium-6/7 Quantum Enrichment facilities. - The Company intends to continue its discussions with nuclear regulatory authorities for the authorization to construct HALEU uranium enrichment facilities using Quantum Enrichment in South Africa and other countries. WASHINGTON, April 01, 202

WASHINGTON, March 31, 2025 (GLOBE NEWSWIRE) -- ASP Isotopes Inc. NASDAQ: ASPI ("ASP Isotopes" or the "Company"), announced that it will release its fourth quarter and fiscal year 2024 financial results after the close of financial markets today, March 31, 2025, with a webinar to follow tomorrow, Tuesday, April 1, 2025 at 10:00 am ET, 3:00 pm UK time, 4:00 pm South African time. Participating in the webinar will be Paul Mann, Chairman and CEO of the Company. Mr. Mann will give a review of the Company's financial and operating results for 2024 and discuss its corporate strategies and outlook for 2025. Please register for the webinar through this link: https://us02web.zoom.us/webinar/regi

- Silicon-28 is an isotope that is believed to assist in enabling quantum computing and improving the performance of next generation semiconductors for artificial intelligence. - The Company expects to ship commercial product during 2Q25. - The Company has already entered into two purchase agreements with US-based customers for kilogram quantities of Silicon-28 and is in discussions with multiple other global customers for kilogram quantities. WASHINGTON, March 27, 2025 (GLOBE NEWSWIRE) -- ASP Isotopes Inc. NASDAQ: ASPI ("ASP Isotopes" or the "Company"), an advanced materials company dedicated to the development of technology and processes for the production of isotopes

MIAMI, March 26, 2025 (GLOBE NEWSWIRE) -- EmergingGrowth.com a leading independent small cap media portal announces the schedule of the 80th Emerging Growth Conference on March 26 & 27, 2025. The Emerging Growth Conference identifies companies in a wide range of growth sectors, with strong management teams, innovative products & services, focused strategy, execution, and the overall potential for long-term growth. Register for the Conference here. Submit Questions for any of the presenting companies to: [email protected] For updates, follow us on Twitter Day 1 - TodayMarch 26, 2025 11:00Virtual Lobby opens.Register for the Conference.  If you already registered, go back to

MIAMI, March 25, 2025 (GLOBE NEWSWIRE) -- EmergingGrowth.com, a leading independent small cap media portal, announces the schedule of the 80th Emerging Growth Conference on March 26 & 27, 2025. The Emerging Growth Conference identifies companies in a wide range of growth sectors, with strong management teams, innovative products & services, focused strategy, execution, and the overall potential for long-term growth. Register for the Conference here. Submit Questions for any of the presenting companies to: [email protected]. For updates, follow us on Twitter. Day 1March 26, 2025 11:00Virtual Lobby opens.Register for the Conference. If you already registered, go

- The Company has commenced commercial production of enriched Carbon-14 at its first Aerodynamic Separation Process (ASP) enrichment facility. - The Company expects to ship commercial product around the middle of the year. - The Company previously entered into a multi-year, take-or-pay contract with a Canadian customer, valued at a minimum of approximately $2.4 million per annum. WASHINGTON, Feb. 26, 2025 (GLOBE NEWSWIRE) -- ASP Isotopes Inc. NASDAQ: ASPI ("ASP Isotopes" or the "Company"), an advanced materials company dedicated to the development of technology and processes for the production of isotopes for use in multiple industries, today announced that it h

ASP Isotopes invites institutional investors to attend the upcoming virtual event by contacting their Canaccord Genuity representative Paul Mann, Chairman and Chief Executive Officer of ASP Isotopes, will participate in a panel discussion on the future of nuclear fission. The panel will also include representatives from TerraPower and Elementl Power WASHINGTON, Feb. 25, 2025 (GLOBE NEWSWIRE) -- ASP Isotopes Inc. NASDAQ: ASPI ("ASP Isotopes" or the "Company"), an advanced materials company dedicated to the development of technology and processes for the production of isotopes for use in multiple industries, is pleased to share that ASP Isotopes will participate in the Canaccord Genuit

MIAMI, Feb. 19, 2025 (GLOBE NEWSWIRE) -- EmergingGrowth.com a leading independent small cap media portal announces the schedule of the 79th Emerging Growth Conference on February 18 & 19, 2025. The Emerging Growth Conference identifies companies in a wide range of growth sectors, with strong management teams, innovative products & services, focused strategy, execution, and the overall potential for long-term growth. Register for the Conference here. Submit Questions for any of the presenting companies to: [email protected] For updates, follow us on Twitter Day 2 - TodayFebruary 19, 2025 Replay Day 1 here:https://emerginggrowt

MIAMI, Feb. 18, 2025 (GLOBE NEWSWIRE) -- EmergingGrowth.com a leading independent small cap media portal announces the schedule of the 79th Emerging Growth Conference on February 18 & 19, 2025. The Emerging Growth Conference identifies companies in a wide range of growth sectors, with strong management teams, innovative products & services, focused strategy, execution, and the overall potential for long-term growth. Register for the Conference here. Submit Questions for any of the presenting companies to: [email protected] For updates, follow us on Twitter Day 1February 18, 2025 9:30Virtual Lobby opens.Register for the Conference. If you already registered, go back to the

WASHINGTON, June 13, 2024 (GLOBE NEWSWIRE) -- ASP Isotopes Inc. NASDAQ: ASPI ("ASP Isotopes" or the "Company"), an advanced materials company dedicated to the development of technology and processes for the production of isotopes for use in multiple industries, today announced the appointment of Heather Kiessling as its chief financial officer (CFO), effective as of July 1, 2024 (or such earlier date as may be mutually agreed), to support the Company's next pivotal phase of growth. Robert Ainscow, who currently serves as the Company's CFO and chief operating officer (COO), will continue to serve as the Company's COO, enabling him to focus his full time and attention on the Company's operat

WASHINGTON, Oct. 19, 2023 (GLOBE NEWSWIRE) -- ASP Isotopes Inc. (NASDAQ:ASPI) ("ASPI", the "Company", "us", "we" or "our"), an advanced materials company dedicated to the development of technology and processes designed to produce isotopes for use in multiple industries, today announced that Professor Mike Gorley, Chief Technologist at the UK Atomic Energy Authority is to join the board of directors of the Company. Professor Gorley is Chief Technologist at the UK Atomic Energy Authority and a visiting Professor at the University of Bristol, U.K. He is a well-known expert in fusion technology and fusion materials. In 2014, Mike was awarded a Ph.D. (DPhil) in Materials Science from Oxford

4 - ASP Isotopes Inc. (0001921865) (Issuer)

4 - ASP Isotopes Inc. (0001921865) (Issuer)

4 - ASP Isotopes Inc. (0001921865) (Issuer)

4 - ASP Isotopes Inc. (0001921865) (Issuer)

4 - ASP Isotopes Inc. (0001921865) (Issuer)

4 - ASP Isotopes Inc. (0001921865) (Issuer)

4 - ASP Isotopes Inc. (0001921865) (Issuer)

4 - ASP Isotopes Inc. (0001921865) (Issuer)

4 - ASP Isotopes Inc. (0001921865) (Issuer)

4 - ASP Isotopes Inc. (0001921865) (Issuer)

144 - ASP Isotopes Inc. (0001921865) (Subject)

8-K - ASP Isotopes Inc. (0001921865) (Filer)

SCHEDULE 13G - ASP Isotopes Inc. (0001921865) (Subject)

S-8 - ASP Isotopes Inc. (0001921865) (Filer)

8-K - ASP Isotopes Inc. (0001921865) (Filer)

10-K - ASP Isotopes Inc. (0001921865) (Filer)

8-K - ASP Isotopes Inc. (0001921865) (Filer)

8-K - ASP Isotopes Inc. (0001921865) (Filer)

8-K - ASP Isotopes Inc. (0001921865) (Filer)

SCHEDULE 13G/A - ASP Isotopes Inc. (0001921865) (Subject)

4 - ASP Isotopes Inc. (0001921865) (Issuer)

4 - ASP Isotopes Inc. (0001921865) (Issuer)

4 - ASP Isotopes Inc. (0001921865) (Issuer)

4 - ASP Isotopes Inc. (0001921865) (Issuer)

4 - ASP Isotopes Inc. (0001921865) (Issuer)

5 - ASP Isotopes Inc. (0001921865) (Issuer)

5 - ASP Isotopes Inc. (0001921865) (Issuer)

4 - ASP Isotopes Inc. (0001921865) (Issuer)

4 - ASP Isotopes Inc. (0001921865) (Issuer)

4 - ASP Isotopes Inc. (0001921865) (Issuer)

Canaccord Genuity initiated coverage of ASP Isotopes with a rating of Buy and set a new price target of $4.50

H.C. Wainwright initiated coverage of ASP Isotopes with a rating of Buy and set a new price target of $3.25

SC 13G - ASP Isotopes Inc. (0001921865) (Subject)

SC 13G/A - ASP Isotopes Inc. (0001921865) (Subject)

SC 13G - ASP Isotopes Inc. (0001921865) (Subject)